New High-Security Laboratory Expands Virus Research in Marburg
The new €50 million BSL-4 facility will triple capacity for research on highly pathogenic viruses, expanding Marburg University’s vital role in combating life-threatening outbreaks.

The Philipps-Universität Marburg (Marburg University) is building a new high-security laboratory to advance research on highly pathogenic viruses and enhance preparedness for future outbreaks. The €50 million facility will significantly expand the university’s existing capabilities and create state-of-the-art conditions for international virology research.
Marburg University’s Institute of Virology has long been a key center for the study of infectious diseases. Scientists at the university have been conducting fundamental research on highly contagious viruses for decades, including Ebola, COVID-19, and the Marburg virus. The new facility will build on this foundation, providing around 3,000 square meters of new space, nearly three times the size of the current lab. In addition, 12 new lab workstations will be created, with greater automation to support more efficient, advanced research processes.
The lab will meet the requirements of biosafety level 4 (BSL-4), the highest classification for work with dangerous pathogens. Only four laboratories of this kind exist in Germany, and Marburg is the only university location among them. This unique position underscores the university’s role as a national leader in virology research.
The new facility will further support Marburg’s role in international research initiatives, including its involvement in the European Vaccines Hub. The university’s Institutes of Virology and Medical Microbiology play a leading role in the Hub, contributing to the development of new approaches to combating infectious diseases. With the expanded infrastructure, researchers will benefit from optimal conditions to advance scientific innovation and global collaboration.
The lab is being constructed on the Lahnberge campus, in close proximity to the existing facility, and is scheduled to open in 2027.
The investment in Marburg reinforces Hessen’s reputation as a center for cutting-edge life sciences research. The new high-security laboratory not only expands critically needed research capacity but also enhances the region’s attractiveness to leading scientists.